• head_banner_01

Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Bear "Customer initially, High quality first" in mind, we do the job closely with our customers and supply them with efficient and skilled providers for Dibutyl Phthalate 84-74-2, Nafcillin Sodium, Active Acetate, We keep on with supplying integration alternatives for customers and hope to create long-term, steady, sincere and mutual advantageous interactions with consumers. We sincerely anticipate your check out.
Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

We're going to commit ourselves to giving our esteemed customers along with the most enthusiastically considerate providers for Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Barcelona, Ukraine, Rio de Janeiro, We have been fully aware of our customer's needs. We deliver high quality products, competitive prices and the first class service. We would like to establish good business relationships as well as friendship with you in the near future.
  • We are a small company that has just started, but we get the company leader's attention and gave us a lot of help. Hope we can make progress together!
    5 Stars By Samantha from Russia - 2017.11.29 11:09
    Production management mechanism is completed, quality is guaranteed, high credibility and service let the cooperation is easy, perfect!
    5 Stars By Marguerite from Philippines - 2018.02.21 12:14
    Write your message here and send it to us